Mesenchymal Stromal Cell-Derived Exosomes and Extracellular Vesicles Across Therapeutic Indications: A Structured Review of Published Preclinical and Early-Phase Clinical Study Designs, Administration Parameters, and Reported Outcomes
Author: Andrew J. Hillman (ORCID 0009-0001-5396-321X)
Published: 2026-07-05, Zenodo
DOI: 10.5281/zenodo.21209815
License: CC BY 4.0
Exosome and mesenchymal stem cell-derived extracellular vesicle products are not approved by the FDA for any indication. This paper describes published scientific literature. It does not describe an available treatment.
Read the full paper at its permanent record: doi.org/10.5281/zenodo.21209815.